AABB participates in a variety of meetings and collaborations:
Meeting Summary between AABB and the European Commission (DG SANTE B4)
AABB and the ISCT have formed a Joint Working Group, as a collaborative effort to identify and facilitate project(s) of common interest to both organizations.
AABB/ISCT Working Group Update - 4/4/19
The Cellular Therapy FDA Liaison Meeting brings together representatives from the cellular therapy community with FDA and other relevant federal government agencies to exchange information on topics of mutual interest.
FDA Liaison Meeting - 12/08/23
FDA Liaison Meeting - 11/15/21
FDA Liaison Meeting - 11/21/19
FDA Liaison Meeting - 3/05/19
FDA Liaison Meeting - 1/30/18
FDA Liaison Meeting - 10/19/16
2018 Center for Biologics Evaluation and Research Science Symposium
Days 1 and 2 videos are available
REGULATORY UPDATE: FDA Releases HCT/P Guidance Documents Related to Donor Eligibility
January 07, 2025
FDA Approves First MSC Therapy to Treat GvHD
January 02, 2025
BioBridge Global Launches BBG Advanced Therapies Subsidiary
January 02, 2025